3P Biopharmaceuticals y Biovian se unen para formar 3PBIOVIAN, una CDMO de medicamentos biológicos líder en Europa

by 3P Biopharmaceuticals

The combined Group, named 3PBIOVIAN, will offer unparalleled end-to-end development and manufacturing services for all protein expression systems and viral vectors, both for Drug Substance and Drug Pr...

Read more

3P Biopharmaceuticals: forjando un legado de innovación y excelencia en biotecnología

by 3P Biopharmaceuticals

La empresa recibe el premio a la Mejor Trayectoria Viveros CEIN en el Congreso Internacional de Emprendimiento de Alto Impacto

Read more

3P Biopharmaceuticals continues its successful collaboration with Toleranzia AB to fight Myasthenia Gravis

by 3P Biopharmaceuticals

​3P Biopharmaceuticals and the Swedish company, Toleranzia AB, have successfully accomplished 1000 L full-scale GMP manufacturing of TOL2 drug substance destinated to be used in clinical study.

Read more

3P Biopharmaceuticals lands in the United States

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological drugs advances its internatio...

Read more

3P Biopharmaceuticals continues its collaboration with U.S. biotech Zhittya for the treatment of Parkinson’s disease

by 3P Biopharmaceuticals

3P Biopharmaceuticals and the American biotech company, Zhittya Genesis Medicine (Zhittya), have successfully accomplished the process transfer and GMP supply of FGF-1 candidate.

Read more

3P Biopharmaceuticals continues its collaboration with U.S. biotech Zhittya for the treatment of Parkinson’s disease

by 3P Biopharmaceuticals

3P Biopharmaceuticals and the American biotech company, Zhittya Genesis Medicine (Zhittya), have successfully accomplished the process transfer and GMP supply of FGF-1 candidate.

Read more

3P Biopharmaceuticals avanza en su plan de expansión y adecuación de sus instalaciones

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), organización líder especializada en el desarrollo de procesos cGMP y fabricación de medicamentos biológicos (CDMO) estrena su tercera instalación en el polígono Mocho...

Read more

3P Biopharmaceuticals increases its microbial production capacity with the installation of a 500 L fermenter

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological products complements its exis...

Read more

3P Biopharmaceuticals has a 68% female workforce with a scientific background

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological products has a 68% female wor...

Read more

BrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeoprotein Engrailed-1

by 3P Biopharmaceuticals

3P Bio will focus on the transfer of the production process as well as the cGMP manufacturing of the drug substance to be used in Phase I and II clinical trials. The novel drug could cure neurodegene...

Read more

3P Biopharmaceuticals entre las 100 mejores empresas para trabajar en España

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), organización líder especializada en el desarrollo de procesos cGMP y fabricación de productos biológicos (CDMO) ha sido seleccionada como una de las 100 mejores empresa...

Read more

3P Biopharmaceuticals appoints Kenneth McMahon as Head of Quality Control

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), a leading organization specializing in the development of cGMP processes and manufacturing of biological products (CDMO) appoints a new member as head of quality control.

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Avamed Synergy renueva su sello de PYME ...

by Avamed Synergy

Con esta ampliación, la compañía sigue posicionándose como empresa...

Photos Stream